Related Experiment Video
Updated: Aug 10, 2025
05:46
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
4.9K
Nitric oxide mediated hypoxia dynamics in COVID-19
1Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.
Nitric Oxide : Biology and Chemistry
|February 12, 2023
Summary
Nitric oxide (NO) impacts COVID-19's "happy hypoxia" by influencing oxygen levels and oxidative stress. Precise NO dosing may treat hypoxemia and reduce inflammation, highlighting NO's role in disease pathogenesis.
Area of Science:
- Biomedical Science
- Respiratory Medicine
- Pathophysiology
Background:
- COVID-19 patients often exhibit
- happy hypoxia,
- characterized by low blood oxygen levels without severe respiratory distress.
- Nitric oxide (NO) levels in COVID-19 patients vary, sometimes exceeding those in other hypoxemic individuals.
- Oxidative stress and reactive oxygen species (ROS) contribute to hypoxia-mediated mortality in COVID-19 by impairing NO signaling and mitochondrial function.
Purpose of the Study:
- To investigate the multifaceted role of nitric oxide (NO) in the pathophysiology of COVID-19, particularly in relation to
- happy hypoxia.
- To explore the therapeutic potential of modulating NO levels in managing COVID-19-associated hypoxemia and inflammation.
Main Methods:
- Review of existing literature on nitric oxide (NO) metabolism, oxidative stress, and mitochondrial function in COVID-19.
- Analysis of reported NO levels in COVID-19 patients compared to non-COVID-19 hypoxemic controls.
- Examination of the effects of inhaled NO (iNO) therapy and nitric oxide synthase (NOS) inhibitors in hypoxemic conditions.
Main Results:
- Excessive ROS and oxidative stress in COVID-19 reduce NO bioavailability, leading to mitochondrial dysfunction and hypoxia.
- Both elevated and decreased NO levels within mitochondria can contribute to cellular dysfunction.
- Targeted NO administration may improve oxygenation and mitigate the cytokine storm associated with severe COVID-19.
Conclusions:
- Nitric oxide (NO) is a critical factor in COVID-19 pathogenesis, influencing both hypoxemia and systemic inflammation.
- Therapeutic strategies involving precise NO modulation, potentially combined with NOS inhibitors, warrant further investigation.
- Development of a reliable biomarker to monitor NO levels is crucial for managing COVID-19 patients with
- happy hypoxia.
Related Concept Videos
01:23Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
01:28Nitric Oxide Signaling Pathway
5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
01:21Acute Respiratory Failure-II
314
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
01:23Physiological Control of Respiration
2.2K
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
2.2K
01:27Oxygen Transport in the Blood
3.0K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
3.0K
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
294
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
294